NPI registry status
Active
2026 NPPES data Primary Care Nurse Practitioner NPI 1063782688 N.P.
Verify on CMS → Sara Devita, N.P.
Primary Care Nurse Practitioner in Wantagh, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 10,179 in Primary Care Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
829
Medicare Part D claims · 256 beneficiaries · Primary Care Nurse Practitioner avg: 1K
Generic prescribing
86%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.3/100
▲ 8 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Sara Devita, N.P. reported a CMS MIPS final score of 91.3/100 - above the 83.1 national average - and filed 829 Medicare Part D claims in 2023.
- 91.3/100
- MIPS score · +8 vs avg
- 829
- Part D claims, 2023
- 86%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Sara Devita, N.P.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
91 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sara Devita, N.P. sits
This provider among primary care nurse practitioner peers
Across the 958 primary care nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Sara Devita, N.P. writes more Part D claims than 55% of them and scores higher on MIPS quality than 63% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one primary care nurse practitioner peer from a representative sample of 60; the gold marker is Sara Devita, N.P.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Sara Devita, N.P.?
High performer (top quartile)Primary specialty
Primary Care Nurse Practitioner
Medicare Part D claims
829 39% vs specialty avg
MIPS final score
91.3/100 8.2 pts vs avg
Specialty distribution in New York
How Primary Care Nurse Practitioner compares to other specialties among New York providers
Medicare quality performance, MIPS
Sara Devita, N.P.'s 2023 MIPS final score plotted against the Primary Care Nurse Practitioner national average
- MIPS Final Score
- 91.3/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Primary Care Nurse Practitioner) - 91.3/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Sara Devita, N.P. appears in the CMS NPPES registry as a Primary Care Nurse Practitioner provider holding N.P. credentials at 2857 JERUSALEM AVE, Wantagh, NY, 11793, with a listed phone of (516) 785-2783. NPI 1063782688 was issued on 01/12/2012.
Medicare Part D records for calendar year 2023 show 829 prescription claims written by this provider, covering 256 Medicare beneficiaries and totaling roughly $50K in drug spend, split 12% brand-name and 86% generic by claim count, with an opioid prescribing rate of 2.3%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.3/100 for the 2023 performance year (Quality 74.9), compared with the national average of 83.1.
Primary Care Nurse Practitioner is a mid-sized specialty nationwide, with 10,179 enrolled providers across 54 states and an average of 1,363 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1063782688 |
|---|---|
| Specialty | Primary Care Nurse Practitioner |
| Credentials | N.P. |
| Gender | Female |
| NPI Issued | 01/12/2012 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.2532
Final Score
Avg: 83.1
74.9203
Quality
91.6794
Promoting Interoperability
Reporting: Alternative Payment Model
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Sara Devita, N.P.. To verify Sara Devita, N.P.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Sara Devita, N.P. - brand share 12.0%
Primary Care Nurse Practitioner average
12% brand-name claims vs 86% generic, on 829 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
829
Total Claims
$50K
Total Drug Cost
256
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,397
- Total Day Supply
- 35,492
- Brand vs Generic
- 12% brand / 86% generic
- Brand Drug Cost
- $39K
- Generic Drug Cost
- $10K
- Opioid Claims
- 19 (2.3% rate)
- Antibiotic Claims
- 152
Patient Demographics
- Average Patient Age
- 73.5 years
- Avg HCC Risk Score
- 0.93
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 16, 65-74: 131, 75-84: 75, 85+: 34
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sara Devita, N.P. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Cefuroxime
Cefuroxime
55 claims
- Alprazolam
Alprazolam
39 claims
- Atorvastatin Calcium
Atorvastatin Calcium
39 claims
- Fluticasone Propio…
Fluticasone Propionate
33 claims
- Amoxicillin-Clavul…
Amoxicillin-Clavulanate Potass
29 claims
- Amlodipine Besylate
Amlodipine Besylate
27 claims
- Doxycycline Hyclate
Doxycycline Hyclate
25 claims
- Levothyroxine Sodium
Levothyroxine Sodium
24 claims
| Drug | Claims |
|---|---|
| Cefuroxime Cefuroxime Axetil | 55 |
| Alprazolam | 39 |
| Atorvastatin Calcium | 39 |
| Fluticasone Propionate | 33 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 |
| Amlodipine Besylate | 27 |
| Doxycycline Hyclate | 25 |
| Levothyroxine Sodium | 24 |
| Escitalopram Oxalate | 21 |
| Rosuvastatin Calcium | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Primary Care Nurse Practitioner Overview
How Sara Devita, N.P. fits within the Primary Care Nurse Practitioner landscape nationally.
10,179
Primary Care Nurse Practitioner Providers in US
54
States with Primary Care Nurse Practitioner
1,363
Avg Claims per Provider
Sara Devita, N.P.'s 829 claims are below the specialty average of 1,363.
Nearby Primary Care Nurse Practitioner Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Devita.
Dr. Mona Aboulnaja
APN-C
New York, NY
Abimbola Adebajo
Bay Shore, NY
Dr. Gifty Adjei-Dugbatey
FNP
Hawthorne, NY
Nurjahan Akter
Elmhurst, NY
Dr. Mariana Allsop
A-GNP-C
Brooklyn, NY
Compare Primary Care Nurse Practitioner nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Primary Care Nurse Practitioner peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Sara Devita, N.P.'s specialty? ▼
Sara Devita, N.P. specializes in Primary Care Nurse Practitioner and practices in Wantagh, New York. Credentials: N.P..
How much does Sara Devita, N.P. prescribe under Medicare Part D? ▼
In 2023, Sara Devita, N.P. wrote 829 Medicare Part D claims totaling $50K in drug costs for 256 beneficiaries.
What is Sara Devita, N.P.'s Medicare quality score? ▼
Sara Devita, N.P. has a CMS MIPS Final Score of 91.3/100 (Quality: 74.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Sara Devita, N.P. located? ▼
Sara Devita, N.P. is located at 2857 JERUSALEM AVE, Wantagh, NY, 11793. Phone: (516) 785-2783.
What is Sara Devita, N.P.'s NPI number? ▼
Sara Devita, N.P.'s National Provider Identifier (NPI) is 1063782688, issued on 01/12/2012.
Does Sara Devita, N.P. prescribe more brand-name or generic drugs? ▼
Sara Devita, N.P.'s prescribing is 12% brand-name and 86% generic drugs by claim count, with $39K in brand drug costs.
Does Sara Devita, N.P. prescribe opioids? ▼
Yes, Sara Devita, N.P. had 19 opioid claims in 2023 with an opioid prescribing rate of 2.3%.
How many Primary Care Nurse Practitioner providers are there in the US? ▼
There are 10,179 Primary Care Nurse Practitioner providers across 54 states in the US. The average Primary Care Nurse Practitioner provider writes 1,363 Medicare Part D claims per year.
What drugs does Sara Devita, N.P. prescribe most often? ▼
Based on 2023 Medicare Part D data, Sara Devita, N.P.'s most frequently prescribed drugs include Cefuroxime, Alprazolam, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sara Devita, N.P. accept Medicare? ▼
Sara Devita, N.P. appears in CMS Medicare data with 829 Part D claims and 256 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sara Devita, N.P.'s credentials? ▼
Sara Devita, N.P.'s NPI is 1063782688 with credentials N.P.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.